During the past decade, Arkhangelsk the first city clinical hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Arkhangelsk the first city clinical hospital" are "Diabetes Mellitus, Type 2" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Arkhangelsk the first city clinical hospital" in a lesser frequency.

Most popular intervention types in "Arkhangelsk the first city clinical hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dulaglutide" (1 trials), "Insulin Glargine" (1 trials) and "Tirzepatide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arkhangelsk the first city clinical hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Arkhangelsk the first city clinical hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Arkhangelsk the first city clinical hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Arkhangelsk the first city clinical hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Arkhangelsk the first city clinical hospital has several departments that took part in Clinical trials: "UZ Vitebsk Regional Childrens Clinical Centre" - 2 trials